cureVision

Seed · Healthtech · Munich, Germany · 10–20 employees

cureVision revolutionizes chronic wound analysis through AI-powered optical sensors and computer vision, providing 90% faster wound assessment with 98% accuracy compared to traditional paper ruler methods. The company has won multiple prestigious awards including the Bavarian Innovation Prize 2024, Health-i Award 2023, and Novartis Digital Health Award. Their MDR-approved system enables automated 3D wound measurement, tissue analysis, and documentation in just two minutes, serving hospitals, nursing homes, and care facilities across Europe with plans for US market entry in 2026.

Open roles at cureVision (1)